156 related articles for article (PubMed ID: 2233726)
21. Characterization of Xenopus laevis oocyte farnesyl transferase.
Goalstone ML; Diamond CL; Sadler SE
Biol Reprod; 1996 Mar; 54(3):675-81. PubMed ID: 8835391
[TBL] [Abstract][Full Text] [Related]
22. Peptidomimetic inhibitors of Ras farnesylation and function in whole cells.
Garcia AM; Rowell C; Ackermann K; Kowalczyk JJ; Lewis MD
J Biol Chem; 1993 Sep; 268(25):18415-8. PubMed ID: 8360140
[TBL] [Abstract][Full Text] [Related]
23. Isoprenoids influence expression of Ras and Ras-related proteins.
Holstein SA; Wohlford-Lenane CL; Hohl RJ
Biochemistry; 2002 Nov; 41(46):13698-704. PubMed ID: 12427032
[TBL] [Abstract][Full Text] [Related]
24. J-104,871, a novel farnesyltransferase inhibitor, blocks Ras farnesylation in vivo in a farnesyl pyrophosphate-competitive manner.
Yonemoto M; Satoh T; Arakawa H; Suzuki-Takahashi I; Monden Y; Kodera T; Tanaka K; Aoyama T; Iwasawa Y; Kamei T; Nishimura S; Tomimoto K
Mol Pharmacol; 1998 Jul; 54(1):1-7. PubMed ID: 9658183
[TBL] [Abstract][Full Text] [Related]
25. Enzymatic coupling of cholesterol intermediates to a mating pheromone precursor and to the ras protein.
Schafer WR; Trueblood CE; Yang CC; Mayer MP; Rosenberg S; Poulter CD; Kim SH; Rine J
Science; 1990 Sep; 249(4973):1133-9. PubMed ID: 2204115
[TBL] [Abstract][Full Text] [Related]
26. ras-p21 activates phospholipase D and A2, but not phospholipase C or PKC, in Xenopus laevis oocytes.
Carnero A; Dolfi F; Lacal JC
J Cell Biochem; 1994 Apr; 54(4):478-86. PubMed ID: 8014197
[TBL] [Abstract][Full Text] [Related]
27. Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturation.
Kovac C; Clie L; Morin J; Friedman FK; Robinson R; Chung DL; Kanovsky M; Flom J; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
Cancer Chemother Pharmacol; 2001 Jul; 48(1):9-14. PubMed ID: 11488531
[TBL] [Abstract][Full Text] [Related]
28. Replacement of the H-Ras farnesyl group by lipid analogues: implications for downstream processing and effector activation in Xenopus oocytes.
Dudler T; Gelb MH
Biochemistry; 1997 Oct; 36(41):12434-41. PubMed ID: 9376347
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of ras-induced oocyte maturation by peptides from ras-p21 and GTPase activating protein (GAP) identified as being effector domains from molecular dynamics calculations.
Friedman FK; Chie L; Chung D; Robinson R; Brandt-Rauf P; Yamaizumi Z; Pincus MR
J Protein Chem; 2002 Jul; 21(5):361-6. PubMed ID: 12206510
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic and activated wild-type ras-p21 proteins induce different isoforms of protein kinase C in mitogenic signal transduction.
Chie L; Qu Y; Chung D; Boutjdir M; Pincus MR
J Protein Chem; 2003 Nov; 22(7-8):625-9. PubMed ID: 14714729
[TBL] [Abstract][Full Text] [Related]
31. A peptide from the GAP-binding domain of the ras-p21 protein and azatyrosine block ras-induced maturation of Xenopus oocytes.
Chung DL; Brandt-Rauf P; Murphy RB; Nishimura S; Yamaizumi Z; Weinstein IB; Pincus MR
Anticancer Res; 1991; 11(4):1373-8. PubMed ID: 1746893
[TBL] [Abstract][Full Text] [Related]
32. Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice.
Sebti SM; Tkalcevic GT; Jani JP
Cancer Commun; 1991 May; 3(5):141-7. PubMed ID: 2043425
[TBL] [Abstract][Full Text] [Related]
33. Two upstream cysteines and the CAAX motif but not the polybasic domain are required for membrane association of Xlcaax in Xenopus oocytes.
Kloc M; Li XX; Etkin LD
Biochemistry; 1993 Aug; 32(32):8207-12. PubMed ID: 8347620
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations. Selective inhibition of oncogenic ras-p21.
Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
J Protein Chem; 1999 Nov; 18(8):875-9. PubMed ID: 10839624
[TBL] [Abstract][Full Text] [Related]
35. Specific labeling of isoprenylated proteins: application to study inhibitors of the post-translational farnesylation and geranylgeranylation.
Danesi R; McLellan CA; Myers CE
Biochem Biophys Res Commun; 1995 Jan; 206(2):637-43. PubMed ID: 7826382
[TBL] [Abstract][Full Text] [Related]
36. Differential inhibitory effects of lovastatin on protein isoprenylation and sterol synthesis.
Sinensky M; Beck LA; Leonard S; Evans R
J Biol Chem; 1990 Nov; 265(32):19937-41. PubMed ID: 2246270
[TBL] [Abstract][Full Text] [Related]
37. Effect of synthetic peptides representing the hypervariable region of p21ras on Xenopus laevis oocyte maturation.
Soto-Cruz I; Magee AI
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):11-4. PubMed ID: 7864796
[TBL] [Abstract][Full Text] [Related]
38. Carboxyl-terminal isoprenylation of ras-related GTP-binding proteins encoded by rac1, rac2, and ralA.
Kinsella BT; Erdman RA; Maltese WA
J Biol Chem; 1991 May; 266(15):9786-94. PubMed ID: 1903399
[TBL] [Abstract][Full Text] [Related]
39. A peptide from the GAP-binding domain of the ras-p21 protein as well as azatyrosine block ras-induced maturation of Xenopus oocytes.
Chung DL; Brandt-Rauf P; Murphy RB; Nishimura S; Yamaizumi Z; Weinstein IB; Pincus MR
Biochem Biophys Res Commun; 1991 Dec; 181(3):1378-84. PubMed ID: 1764089
[TBL] [Abstract][Full Text] [Related]
40. High glucose induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway.
Mather A; Chen XM; McGinn S; Field MJ; Sumual S; Mangiafico S; Zhang Y; Kelly DJ; Pollock CA
Int J Biochem Cell Biol; 2009 Mar; 41(3):561-9. PubMed ID: 18692592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]